Micheliolide is primarily researched for its potential therapeutic applications, particularly in the fields of oncology and immunology. It has shown promising anti-inflammatory properties, making it a candidate for treating inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, micheliolide has been studied for its anti-cancer effects, where it exhibits the ability to inhibit the growth of various cancer cells and induce apoptosis. Its mechanism often involves modulating key signaling pathways like NF-κB, which plays a crucial role in inflammation and cancer progression. Researchers are also exploring its use in combination therapies to enhance the efficacy of existing treatments. Overall, micheliolide holds significant potential as a bioactive compound in drug development for inflammatory and oncological conditions.